홈 › 만성 림프구성 백혈병 › 워싱턴 D.C. › Washington
DC Washington의 만성 림프구성 백혈병 임상 시험
만성 림프구성 백혈병 관련 연구 22개가 Washington 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
피험자 모집 중1/2상
- American Oncology Partners of Maryland Pa, Bethesda · 7마일 거리
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
피험자 모집 중3상
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · 7마일 거리
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
피험자 모집 중관찰 연구
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7마일 거리
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
피험자 모집 중3상
- GC2202 Study Site 111, Bethesda · 7마일 거리
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
피험자 모집 중3상
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7마일 거리
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
피험자 모집 중3상
- American Oncology Partners of Maryland Pa, Bethesda · 7마일 거리
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
피험자 모집 중3상
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
피험자 모집 중관찰 연구
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
피험자 모집 중2상
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
피험자 모집 중관찰 연구건강한 지원자 환영
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
피험자 모집 중3상
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7마일 거리
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
피험자 모집 중2상
- Maryland Oncology Hematology, Silver Spring · 7마일 거리
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
피험자 모집 중초기 1상
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
피험자 모집 중3상
- American Oncology Partners of Maryland, PA, Bethesda · 7마일 거리
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
피험자 모집 중3상
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · 7마일 거리
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
피험자 모집 중1/2상
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
피험자 모집 중1상
- National Institute of Health, Bethesda · 7마일 거리
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
피험자 모집 중2상
- American Oncology Partners, PA, Bethesda · 7마일 거리
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
피험자 모집 중관찰 연구건강한 지원자 환영
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
피험자 모집 중3상
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · 7마일 거리
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · 7마일 거리
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
피험자 모집 중1상
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
다른 도시의 만성 림프구성 백혈병 시험
- Boston, MA연구 31개
- Columbus, OH연구 28개
- Durham, NC연구 27개
- Seattle, WA연구 20개
- New York City, NY연구 18개
- Rochester, MN연구 18개
- Houston, TX연구 17개
- Baldwin Park, CA연구 16개
- Milwaukee, WI연구 15개
- Chicago, IL연구 14개
- Cincinnati, OH연구 14개
- Nashville, TN연구 13개
Washington의 다른 연구
- 암 (전체)연구 58개
- 비소세포폐암연구 55개
- 유방암연구 46개
- 전이성 암연구 43개
- 폐암연구 41개
- 전립선암연구 38개
- 비만연구 33개
- 대장직장암연구 29개
- 심혈관 질환연구 28개
- 방광암연구 26개
- 급성 골수성 백혈병연구 24개
- 난소암연구 23개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.